These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 32457805)

  • 21. Mutational Screening of PKD1 and PKD2 Genes in Iranian Population Diagnosed with Autosomal Dominant Polycystic Kidney Disease.
    Ranjzad F; Tara A; Basiri A; Aghdami N; Moghadasali R
    Clin Lab; 2017 Jul; 63(7):1261-1267. PubMed ID: 28792715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
    Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
    J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modifiers of Autosomal Dominant Polycystic Kidney Disease Severity: The Role of
    Ambrosini E; Montanari F; Cristalli CP; Capelli I; La Scola C; Pasini A; Graziano C
    Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
    Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
    BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
    Carrera P; Calzavara S; Magistroni R; den Dunnen JT; Rigo F; Stenirri S; Testa F; Messa P; Cerutti R; Scolari F; Izzi C; Edefonti A; Negrisolo S; Benetti E; Alibrandi MT; Manunta P; Boletta A; Ferrari M
    Sci Rep; 2016 Aug; 6():30850. PubMed ID: 27499327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single-center analysis of genotype-phenotype characteristics of Chinese patients with autosomal dominant polycystic kidney disease by targeted exome sequencing.
    Yan Z; Wang Y; Deng W; Zhou Y; Hu Y; Qi K; Liu D; Xia R; Liu R; Zeng W; Zhang W; Xu J; Xiong F; Miao Y
    Front Genet; 2022; 13():934463. PubMed ID: 36186434
    [No Abstract]   [Full Text] [Related]  

  • 27. PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan.
    Yu CC; Lee AF; Kohl S; Lin MY; Cheng SM; Hung CC; Chang JM; Chiu YW; Hwang SJ; Otto EA; Hildebrandt F; ; Hwang DY
    NPJ Genom Med; 2022 Jul; 7(1):40. PubMed ID: 35778421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic diagnostics in polycystic kidney disease: an assessment of real-world use of whole-genome sequencing.
    Mallawaarachchi AC; Lundie B; Hort Y; Schonrock N; Senum SR; Gayevskiy V; Minoche AE; Hollway G; Ohnesorg T; Hinchcliffe M; Patel C; Tchan M; Mallett A; Dinger ME; Rangan G; Cowley MJ; Harris PC; Burnett L; Shine J; Furlong TJ
    Eur J Hum Genet; 2021 May; 29(5):760-770. PubMed ID: 33437033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-segregation of candidate polymorphism rs201204878 of the
    Ranjzad F; Tara A; Basiri A; Aghdami N; Moghadasali R
    Exp Ther Med; 2019 Aug; 18(2):1345-1349. PubMed ID: 31384335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel mutations of PKD1 gene in Chinese patients with autosomal dominant polycystic kidney disease by targeted next-generation sequencing.
    Yang T; Meng Y; Wei X; Shen J; Zhang M; Qi C; Wang C; Liu J; Ma M; Huang S
    Clin Chim Acta; 2014 Jun; 433():12-9. PubMed ID: 24582653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Analysis of PKD1 and PKD2 by Long-Read Sequencing in Autosomal Dominant Polycystic Kidney Disease.
    Xu D; Mao A; Chen L; Wu L; Ma Y; Mei C
    Clin Chem; 2024 Jun; 70(6):841-854. PubMed ID: 38527221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular diagnosis of autosomal dominant polycystic kidney disease using next-generation sequencing.
    Tan AY; Michaeel A; Liu G; Elemento O; Blumenfeld J; Donahue S; Parker T; Levine D; Rennert H
    J Mol Diagn; 2014 Mar; 16(2):216-28. PubMed ID: 24374109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel heterozygous PKD1 variant causing alternative splicing in a Chinese family with autosomal dominant polycystic kidney disease.
    Zhao Q; Tan Y; Xiao X; Xiang Q; Yang M; Wang H; Liu S
    Mol Genet Genomic Med; 2023 Aug; 11(8):e2217. PubMed ID: 37272738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Diagnosis and Identification of Novel Pathogenic Variants in a Large Cohort of Italian Patients Affected by Polycystic Kidney Diseases.
    Nigro E; Amicone M; D'Arco D; Sellitti G; De Marco O; Guarino M; Riccio E; Pisani A; Daniele A
    Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel PKD1 and PKD2 mutations in Taiwanese patients with autosomal dominant polycystic kidney disease.
    Chang MY; Chen HM; Jenq CC; Lee SY; Chen YM; Tian YC; Chen YC; Hung CC; Fang JT; Yang CW; Wu-Chou YH
    J Hum Genet; 2013 Nov; 58(11):720-7. PubMed ID: 23985799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease.
    Obeidova L; Elisakova V; Stekrova J; Reiterova J; Merta M; Tesar V; Losan F; Kohoutova M
    BMC Med Genet; 2014 Apr; 15():41. PubMed ID: 24694054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System.
    Kinoshita M; Higashihara E; Kawano H; Higashiyama R; Koga D; Fukui T; Gondo N; Oka T; Kawahara K; Rigo K; Hague T; Katsuragi K; Sudo K; Takeshi M; Horie S; Nutahara K
    PLoS One; 2016; 11(11):e0166288. PubMed ID: 27835667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blocker displacement amplification-based genetic diagnosis for autosomal dominant polycystic kidney disease and the clinical outcomes of preimplantation genetic testing.
    Lin T; Luo J; Yu H; Dong B; Zhang Q; Zhang W; Chen K; Xiang Y; Liu D; Huang G
    J Assist Reprod Genet; 2023 Apr; 40(4):783-792. PubMed ID: 36773205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.
    Senum SR; Li YSM; Benson KA; Joli G; Olinger E; Lavu S; Madsen CD; Gregory AV; Neatu R; Kline TL; Audrézet MP; Outeda P; Nau CB; Meijer E; Ali H; Steinman TI; Mrug M; Phelan PJ; Watnick TJ; Peters DJM; Ong ACM; Conlon PJ; Perrone RD; Cornec-Le Gall E; Hogan MC; Torres VE; Sayer JA; ; Harris PC
    Am J Hum Genet; 2022 Jan; 109(1):136-156. PubMed ID: 34890546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Analysis of Severe Polycystic Liver Disease in Japan.
    Mizuno H; Besse W; Sekine A; Long KT; Kurihara S; Oba Y; Yamanouchi M; Hasegawa E; Suwabe T; Sawa N; Ubara Y; Somlo S; Hoshino J
    Kidney360; 2024 Aug; 5(8):1106-1115. PubMed ID: 38689396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.